Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20335583 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A 6-month Efficacy, Safety and Tolerability Study of Rifaximin In Preventing Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Rifaximin
2 Recruiting Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal Bleeding
Conditions: Cirrhosis;   Esophageal and Gastric Varices;   Gastrointestinal Hemorrhage
Intervention: Drug: Rifaximin

Study has passed its completion date and status has not been verified in more than two years.